Risk assessment in travel medicine: how to obtain, interpret, and use risk data for informing pre-travel advice.

BACKGROUND It has been recommended that numerical risk data should be provided during the pre-travel consultation in order for travelers to make informed decisions regarding uptake of preventive interventions. METHODS In this article, we review the definitions of the various risk measures, particularly as they relate to travel health, and discuss the study designs and methodological details required to obtain each measure. RESULTS Risk measures can be broadly divided into absolute risk measures (including incidence rate, attack rate, and incidence density) and risk factor measures (including relative risk, risk ratio, and odds ratio). Although there are limitations inherent to each measure, absolute risk measures estimate the baseline risk for an "average" traveler, and risk factor measures help determine whether the risks for an individual traveler are likely to be higher or lower than this average, which is determined by specific traveler and itinerary characteristics. Incremental risk considerations add additional complexity, and risk communication plus risk perception/risk tolerance have additional impact on the individual traveler's interpretation of risk measures. CONCLUSIONS Travel health practitioners should be aware of the complexities, limitations, and difficulties in understanding numerical risk data, as these factors are important in travelers' acceptance or rejection of interventions offered.

[1]  E. Faerstein A DICTIONARY OF EPIDEMIOLOGY , 2016 .

[2]  D. Stablein,et al.  Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala. , 2014, The Lancet. Infectious diseases.

[3]  C. Greenaway,et al.  Committee to advise on tropical medicine and travel (CATMAT). , 2014, Canada diseases weekly report = Rapport hebdomadaire des maladies au Canada.

[4]  H. Dupont,et al.  Efficacy of a travelers' diarrhea vaccine system in travelers to India. , 2013, Journal of travel medicine.

[5]  R. Behrens,et al.  The challenges of disease risk ascertainment using accessible data sources for numbers of travelers. , 2013, Journal of travel medicine.

[6]  R. Steffen,et al.  Travel medicine for Asian travelers--do we need new approaches? , 2012, Journal of travel medicine.

[7]  L. Noble,et al.  Travel clinic consultation and risk assessment. , 2012, Infectious Disease Clinics of North America.

[8]  Mary E. Wilson,et al.  A comparative analysis of methodological approaches used for estimating risk in travel medicine. , 2008, Journal of travel medicine.

[9]  H. Dupont,et al.  Epidemiology of travelers' diarrhea: details of a global survey. , 2006, Journal of travel medicine.

[10]  M. Mutsch,et al.  Hepatitis A virus infections in travelers, 1988-2004. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  M. Cetron,et al.  Spectrum of disease and relation to place of exposure among ill returned travelers. , 2006, The New England journal of medicine.

[12]  A. Hay,et al.  Influenza virus infection in travelers to tropical and subtropical countries. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  S. Angell,et al.  Risk assessment and disease prevention in travelers visiting friends and relatives. , 2005, Infectious disease clinics of North America.

[14]  Mark Woodward,et al.  Epidemiology: Study Design and Data Analysis , 1999 .

[15]  Steffen,et al.  Update on the Epidemiology of Traveler's Diarrhea in East Africa. , 1997, Journal of travel medicine.

[16]  K. Leder,et al.  Vaccine-preventable travel health risks: what is the evidence--what are the gaps? , 2015, Journal of travel medicine.